Logo
Logo
Subscribe
Logo
Logo

Explore with
Undervalued Edge

Your source for undervalued and overlooked stock recommendations and analysis four times per week


NEWEST

See all
ArrowRight
This Travel Booking Stock Screens at 50% Upside and Nobody Is Boarding
Undervalued Edge

This Travel Booking Stock Screens at 50% Upside and Nobody Is Boarding

A travel booking giant screens at roughly 50% upside, while most Westerners have not updated their view since 2022. Here's what they are missing.

Aug 14, 2026
The SaaS Company That Just Turned GAAP Profitable, Beat Q2 by 30%, and Raised Full-Year EPS Guidance Is Still Trading at a Discount to Peers
Undervalued Edge Analysis

The SaaS Company That Just Turned GAAP Profitable, Beat Q2 by 30%, and Raised Full-Year EPS Guidance Is Still Trading at a Discount to Peers

A SaaS company beat Q2 by 30%, raised guidance, and just achieved GAAP profitability while growing its employee experience platform at the fastest rate in the business. Find out if it belongs in your portfolio.

Aug 13, 2026
This Epilepsy Drug Reaches the FDA This Quarter With Cash Through 2029
Undervalued Edge

This Epilepsy Drug Reaches the FDA This Quarter With Cash Through 2029

This quarter, a neuroscience company files its lead seizure drug with the FDA. Analyst targets run to $100. Here's the setup before the paperwork lands.

Aug 12, 2026
The Medical Imaging Leader With a Record Backlog Reported a Beat, and Has Director Buying to Show for It
Undervalued Edge Analysis

The Medical Imaging Leader With a Record Backlog Reported a Beat, and Has Director Buying to Show for It

A medical imaging leader beat Q2 earnings by 9%, hit a record $23.9 billion backlog, and is reviewing its weakest segment for a potential sale.

Aug 11, 2026
Cocoa Crushed This Chocolate Stock and Now the Damage Is Reversing
Undervalued Edge

Cocoa Crushed This Chocolate Stock and Now the Damage Is Reversing

This chocolate stock got punished when cocoa exploded, but the biggest pressure on margins is finally easing. The valuation now looks far more interesting.

Aug 10, 2026
The Digital Economy of an Entire Country Wrapped Into One App Reports Monday With a 7x Earnings Multiple
Undervalued Edge Analysis

The Digital Economy of an Entire Country Wrapped Into One App Reports Monday With a 7x Earnings Multiple

The company that built the digital infrastructure of an entire economy trades at a massive discount to peers, reports Q2 Monday, and yields nearly 8%. Find out if the setup is worth the country risk.

Aug 8, 2026
The Energy Drink Name the Crowd Abandoned Just Had Its Moment
Undervalued Edge

The Energy Drink Name the Crowd Abandoned Just Had Its Moment

An energy drink name just reported into sentiment that had already gone flat, with the Street looking for nearly 18% growth. The reaction is the real signal here.

Aug 7, 2026
The Company Building the Circuit Boards Inside AI Switches Reports Q2 Earnings Tomorrow
Undervalued Edge Analysis

The Company Building the Circuit Boards Inside AI Switches Reports Q2 Earnings Tomorrow

The company that builds the boards inside AI switches and defense radar systems reports Q2 results tomorrow. Four consecutive earnings beats behind it and 55% growth expected. See if it belongs in your portfolio.

Aug 4, 2026
The Rideshare Underdog Finally Has to Show the Cash It Keeps Talking About
Undervalued Edge

The Rideshare Underdog Finally Has to Show the Cash It Keeps Talking About

A rideshare name with improving ridership, quiet autonomous partnerships, and rock-bottom expectations reports Thursday. Clean cash flow quarter, and it reprices fast.

Aug 3, 2026
Load more

POPULAR

See all
ArrowRight
This Travel Booking Stock Screens at 50% Upside and Nobody Is Boarding

Undervalued Edge

This Travel Booking Stock Screens at 50% Upside and Nobody Is Boarding

Aug 14, 2026

•

7 min read

The SaaS Company That Just Turned GAAP Profitable, Beat Q2 by 30%, and Raised Full-Year EPS Guidance Is Still Trading at a Discount to Peers

Undervalued Edge Analysis

The SaaS Company That Just Turned GAAP Profitable, Beat Q2 by 30%, and Raised Full-Year EPS Guidance Is Still Trading at a Discount to Peers

Aug 13, 2026

•

8 min read

This Epilepsy Drug Reaches the FDA This Quarter With Cash Through 2029

Undervalued Edge

This Epilepsy Drug Reaches the FDA This Quarter With Cash Through 2029

Aug 12, 2026

•

8 min read

The Medical Imaging Leader With a Record Backlog Reported a Beat, and Has Director Buying to Show for It

Undervalued Edge Analysis

The Medical Imaging Leader With a Record Backlog Reported a Beat, and Has Director Buying to Show for It

Aug 11, 2026

•

9 min read

Cocoa Crushed This Chocolate Stock and Now the Damage Is Reversing

Undervalued Edge

Cocoa Crushed This Chocolate Stock and Now the Damage Is Reversing

Aug 10, 2026

•

7 min read

HIDDEN GEMS

See all
ArrowRight
No posts found

ALL POSTS

Explore other posts written by the Putty team.

This Travel Booking Stock Screens at 50% Upside and Nobody Is Boarding
Undervalued Edge

This Travel Booking Stock Screens at 50% Upside and Nobody Is Boarding

A travel booking giant screens at roughly 50% upside, while most Westerners have not updated their view since 2022. Here's what they are missing.

Aug 14, 2026
The SaaS Company That Just Turned GAAP Profitable, Beat Q2 by 30%, and Raised Full-Year EPS Guidance Is Still Trading at a Discount to Peers
Undervalued Edge Analysis

The SaaS Company That Just Turned GAAP Profitable, Beat Q2 by 30%, and Raised Full-Year EPS Guidance Is Still Trading at a Discount to Peers

A SaaS company beat Q2 by 30%, raised guidance, and just achieved GAAP profitability while growing its employee experience platform at the fastest rate in the business. Find out if it belongs in your portfolio.

Aug 13, 2026
This Epilepsy Drug Reaches the FDA This Quarter With Cash Through 2029
Undervalued Edge

This Epilepsy Drug Reaches the FDA This Quarter With Cash Through 2029

This quarter, a neuroscience company files its lead seizure drug with the FDA. Analyst targets run to $100. Here's the setup before the paperwork lands.

Aug 12, 2026
The Medical Imaging Leader With a Record Backlog Reported a Beat, and Has Director Buying to Show for It
Undervalued Edge Analysis

The Medical Imaging Leader With a Record Backlog Reported a Beat, and Has Director Buying to Show for It

A medical imaging leader beat Q2 earnings by 9%, hit a record $23.9 billion backlog, and is reviewing its weakest segment for a potential sale.

Aug 11, 2026
Cocoa Crushed This Chocolate Stock and Now the Damage Is Reversing
Undervalued Edge

Cocoa Crushed This Chocolate Stock and Now the Damage Is Reversing

This chocolate stock got punished when cocoa exploded, but the biggest pressure on margins is finally easing. The valuation now looks far more interesting.

Aug 10, 2026
The Digital Economy of an Entire Country Wrapped Into One App Reports Monday With a 7x Earnings Multiple
Undervalued Edge Analysis

The Digital Economy of an Entire Country Wrapped Into One App Reports Monday With a 7x Earnings Multiple

The company that built the digital infrastructure of an entire economy trades at a massive discount to peers, reports Q2 Monday, and yields nearly 8%. Find out if the setup is worth the country risk.

Aug 8, 2026
The Energy Drink Name the Crowd Abandoned Just Had Its Moment
Undervalued Edge

The Energy Drink Name the Crowd Abandoned Just Had Its Moment

An energy drink name just reported into sentiment that had already gone flat, with the Street looking for nearly 18% growth. The reaction is the real signal here.

Aug 7, 2026
The Company Building the Circuit Boards Inside AI Switches Reports Q2 Earnings Tomorrow
Undervalued Edge Analysis

The Company Building the Circuit Boards Inside AI Switches Reports Q2 Earnings Tomorrow

The company that builds the boards inside AI switches and defense radar systems reports Q2 results tomorrow. Four consecutive earnings beats behind it and 55% growth expected. See if it belongs in your portfolio.

Aug 4, 2026
The Rideshare Underdog Finally Has to Show the Cash It Keeps Talking About
Undervalued Edge

The Rideshare Underdog Finally Has to Show the Cash It Keeps Talking About

A rideshare name with improving ridership, quiet autonomous partnerships, and rock-bottom expectations reports Thursday. Clean cash flow quarter, and it reprices fast.

Aug 3, 2026
Load more

TAGS

Undervalued Edge

Undervalued Edge Analysis


MORE RESOURCES


Video
Tutorials

Folders
Templates

ShootingStar
Creators

SealCheck
Experts

LATEST


This Travel Booking Stock Screens at 50% Upside and Nobody Is Boarding

A travel booking giant screens at roughly 50% upside, while most Westerners have not updated their view since 2022. Here's what they are missing.

Aug 14, 2026

•

7 min read

The SaaS Company That Just Turned GAAP Profitable, Beat Q2 by 30%, and Raised Full-Year EPS Guidance Is Still Trading at a Discount to Peers

A SaaS company beat Q2 by 30%, raised guidance, and just achieved GAAP profitability while growing its employee experience platform at the fastest rate in the business. Find out if it belongs in your portfolio.

Aug 13, 2026

•

8 min read

This Epilepsy Drug Reaches the FDA This Quarter With Cash Through 2029

This quarter, a neuroscience company files its lead seizure drug with the FDA. Analyst targets run to $100. Here's the setup before the paperwork lands.

Aug 12, 2026

•

8 min read

The Medical Imaging Leader With a Record Backlog Reported a Beat, and Has Director Buying to Show for It

A medical imaging leader beat Q2 earnings by 9%, hit a record $23.9 billion backlog, and is reviewing its weakest segment for a potential sale.

Aug 11, 2026

•

9 min read

Cocoa Crushed This Chocolate Stock and Now the Damage Is Reversing

This chocolate stock got punished when cocoa exploded, but the biggest pressure on margins is finally easing. The valuation now looks far more interesting.

Aug 10, 2026

•

7 min read

Load more

COMMUNITY


SlackLogo
Join Slack

YoutubeLogo
Subscribe on YouTube

ArrowUpRight
Subscribe

background

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum

© 2025 Undervalued Edge

Home

Posts

Authors

Lessons